Vor Biopharma Inc logo

Vor Biopharma Inc

NAS:VOR (USA)   Ordinary Shares
$ 1.69 -0.01 (-0.59%) 10:08 PM EST
At Loss
P/B:
0.76
Market Cap:
$ 115.28M
Enterprise V:
$ 14.45M
Volume:
154.02K
Avg Vol (2M):
331.88K
Volume:
154.02K
At Loss
Avg Vol (2M):
331.88K

Business Description

Vor Biopharma Inc logo
Vor Biopharma Inc
NAICS : 325412 SIC : 2834
ISIN : US9290331084

Share Class Description:

VOR: Ordinary Shares
Description
Vor Biopharma Inc is a clinical stage cell therapy company. It combines a novel patient engineering approach with targeted therapies to provide a solution for patients suffering from hematological malignancies. The company's products include VOR33.
Name Current Vs Industry Vs History
Cash-To-Debt 3.85
Equity-to-Asset 0.76
Debt-to-Equity 0.24
Debt-to-EBITDA -0.29
Interest Coverage N/A
N/A
N/A
Piotroski F-Score 2/9
0
1
2
3
4
5
6
7
8
9
WACC vs ROIC
WACC
ROIC

Growth Rank

Name Current Vs Industry Vs History
3-Year EBITDA Growth Rate -13.9
3-Year EPS without NRI Growth Rate -11.8
3-Year FCF Growth Rate -8.9
Name Current Vs Industry Vs History
5-Day RSI 33.35
9-Day RSI 35.98
14-Day RSI 38.51
6-1 Month Momentum % 0.47
12-1 Month Momentum % -51.46

Liquidity Ratio

Name Current Vs Industry Vs History
Current Ratio 9.04
Quick Ratio 9.04
Cash Ratio 8.81

Dividend & Buy Back

Name Current Vs Industry Vs History
3-Year Average Share Buyback Ratio -25.1
Shareholder Yield % -3.57
Name Current Vs Industry Vs History
ROE % -58.3
ROA % -47.18
ROIC % -186.43
ROC (Joel Greenblatt) % -234.61
ROCE % -53.42